Crinetics (CRNX) is up 21.9%, or $7.88 to $43.77.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CRNX:
- Crinetics price target raised to $62 from $58 at Baird
- Buy Rating for Crinetics Pharmaceuticals Driven by FDA Approval and Strategic Market Positioning of Palsonify
- Crinetics Pharmaceuticals Gains FDA Approval for PALSONIFY
- Crinetics price target raised to $143 from $86 at Citizens JMP
- Crinetics announces FDA approval of PALSONIFY